
Sansure Biotech Inc.
SSE:688289.SS
20.25 (CNY) • At close June 10, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Sansure Biotech Inc. |
Symbool | 688289.SS |
Munteenheid | CNY |
Prijs | 19.97 |
Beurswaarde | 11,366,499,038 |
Dividendpercentage | 3.5% |
52-weken bereik | 16.44 - 26.36 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Lizhong Dai |
Website | https://www.sansure.com.cn |
An error occurred while fetching data.
Over Sansure Biotech Inc.
Sansure Biotech Inc. develops and sells upstream nucleic acid extraction kits, real time PCR diagnostic and research kits, and fluorescence systems in China and internationally. The company offers novel coronavirus nucleic acid diagnostic kits; viral hepatitis and AIDS, blood screening, and extraction kits; cancer-related biomarkers; and kits for respiratory tract
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)